Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.07 - Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer
11:35 - 11:45 | Presenter: Junji Tsurutani | Author(s): Haeseong Park, Toshihiko Doi, Shanu Modi, Shunji Takahashi, Kazuhiko Nakagawa, Ian E. Krop, Saiama N. Waqar, Kiyotaka Yoh, Bob T. Li, Shinichiro Taira, Takahiro Jikoh, Jasmeet Singh, Masahiro Sugihara, Pasi A Jänne
- Abstract
Loading...
-
+
OA08 - Mesothelioma: Immunotherapy and microRNA for Diagnosis and Treatment
- 15:15 - 16:45
- 9/24/2018
- Location: Room 201 BD
- Type: Oral Abstract Session
- Track: Mesothelioma
-
+
OA08.01 - Long-Term Efficacy and Safety of Nivolumab in Second- or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)
15:15 - 15:25 | Presenter: Takashi Nakano | Author(s): Morihito Okada, Takashi Kijima, Keisuke Aoe, Tatsuya Kato, Nobukazu Fujimoto, Kazuhiko Nakagawa, Yuichiro Takeda, Toyoaki Hida, Kuninobu Kanai, Fumio Imamura, Satoshi Oizumi, Toshiaki Takahashi, Mitsuhiro Takenoyama, Hiroshi Tanaka, Yuichiro Ohe
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-34 - Docetaxel Plus Ramucirumab with Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)
16:45 - 18:00 | Presenter: Akito Hata | Author(s): Nobuyuki Katakami, Mototsugu Shimokawa, Shunichi Sugawara, Kazumi Nishino, Satoshi Hara, Hideyuki Nakagawa, Masamichi Mineshita, Motoko Tachihara, Koichi Azuma, Osamu Hataji, Hiroshi Tanaka, Toshiaki Takahashi, Toyoaki Hida, Akihiro Bessho, Eriko Tabata, Hiroshi Watanabe, Naoyuki Nogami, Toshihide Yokoyama, Hidetoshi Hayashi, Hiroaki Akamatsu, Isamu Okamoto, Tetsuya Mitsudomi, Nobuyuki Yamamoto, Kazuhiko Nakagawa
- Abstract
Loading...
-
+
P1.14 - Thymoma/Other Thoracic Malignancies (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.14-03 - Phase II Trial of Amrubicin and Cisplatin Chemotherapy for Invasive Thymoma: WJOG5509L
16:45 - 18:00 | Presenter: Keita Kudo | Author(s): Makoto Nishio, Yoshimasa Shikraisi, Akira Ono, Isamu Okamoto, Yasuo Iwamoto, Yuusuke Ookuma, Katsuhiro Okuda, Kohei Akiyoshi, Kazumi Nishino, Shigeki Mituoka, Koichi Azuma, Kiyonobu Ueno, Toyohisa Iriki, Kenji Sugio, Yasutaka Chiba, Yuichi Ishikawa, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.03 - PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial
13:40 - 13:45 | Presenter: Suresh S. Ramalingam | Author(s): Helen Brown, Johan F. Vansteenkiste, Kazuhiko Nakagawa, Manuel Cobo Dols, Thomas John, Craig Barker, Alexander Kohlmann, Alexander Todd, Matilde Saggese, Juliann Chmielecki, Aleksandra Markovets
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.01-75 - RELAY+, an Exploratory Study of Gefitinib with Ramucirumab in Untreated Patients with EGFR Mutation-Positive Metastatic NSCLC
12:00 - 13:30 | Presenter: Makoto Nishio | Author(s): Kazuto Nishio, Kazumi Suzukawa, Yukie Omori, Sotaro Enatsu, Carla Visseren-Grul, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P3.01-96 - Clinical Characteristics of Non–Small Cell Lung Cancer Harboring Mutations in Exon 20 Of EGFR or HER2
12:00 - 13:30 | Presenter: Masayuki Takeda | Author(s): Kazuko Sakai, Hidetoshi Hayashi, Kaoru Tanaka, Junko Tanizaki, Takayuki Takahama, Koji Haratani, Kazuto Nishio, Kazuhiko Nakagawa
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.04-29 - Efficacy of Re-Treatment with Immune Checkpoint Inhibitors in Patients with Pretreated Advanced Non-Small Cell Lung Carcinoma
12:00 - 13:30 | Presenter: Takayuki Takahama | Author(s): Masayuki Takeda, Koji Haratani, Kaoru Tanaka, Hidetoshi Hayashi, Kazuhiko Nakagawa
- Abstract
Loading...
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- 13:30 - 15:00
- 9/26/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA26.11 - Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
14:40 - 14:45 | Presenter: Yi-Long Wu | Author(s): Tony S. Mok, Kazuhiko Nakagawa, Rafael Rosell, Ki Hyeong Lee, Jesus Corral, Maria Rita Migliorino, Adam Pluzanski, Rolf Linke, Geeta Devgan, Eric I. Sbar, Susan Quinn, Tao Wang
- Abstract
Loading...